Container Closure Integrity Assurance: Building Reliable Product Protection for Sterile Products
Assuring container closure integrity (CCI) for an injectable product presentation is a governing principle that must be systemically applied during design, development , manufacturing, distribution and use of a sterile product in order to secure product’s SISPQ (Safety, Identity, Strength, Potency, and Quality) at all times. Injectable drugs must be manufactured to be sterile, and remain so until administration to the patient. For pharmaceutical manufacturers, creating and maintaining the integrity of a container closure system is a requirement described in numerous regulatory and quality standards across global or regional regulations in the world.
Sterility of a product It is a critical attribute and must be first created and than protected across the product life cycle. It is a regulatory expectation and a critical component of patient safety. Passing sterility is a requirement for any injectable product batch. Sterility test is however a verification test only, performed on a few selected product units. In a similar way to the Sterility test, CCIT or CCI testing verifies only a few units. Sterility and CCI tests alone cannot guarantee that all units in a batch have the desired attributes.
terility Assurance must be embedded in all elements and activities required during manufacturing of a sterile product. CCI Assurance works in a highly similar way. It starts with elements of assuring components requirements that must fit by design to create inherent integrity and establishing the elements required to protect CCI along product manufacturing, distribution and delivery.
Traditionally, discussions about container closure integrity have focused on testing (CCIT). While integrity testing remains essential, regulators increasingly emphasize that integrity should not be treated only as confirmation or pass/fail test. Instead, pharmaceutical companies are expected to design and operate processes that consistently produce reliable assurance that integrity of the container and quality of the sealing surfaces remain integer throughout the product lifecycle.
Container Closure Integrity Assurance defines the way of working holistically in selecting, handling and controlling the steps involved in creating and maintaining products container closure Integrity. For example, rather than relying solely on a CCIT test to verify the seal quality after completion of a vial product batch, seal assurance is implementing conditions that make reliable sealing possible in the first place. Rather than relying on visual inspection to eliminate defective units containing damaging defects to a vial, syringe, cartridge, we are relying on identifying and eliminating the risks for damaging forces to occur ahead of starting production.
Integrity assurance versus integrity verification paradigm
To understand this shift, it is useful to distinguish between integrity verification (in general a test or group of orthogonal testing methods) and integrity assurance.
Integrity Verification is done on the finished product using a test specific to a product in its packaging configuration.
Integrity Assurance reflects the overall knowledge controls embedded in the manufacturing processes and documentation associated with batch execution based on targeted studies that are assessing the packaging in the context of the process, product and equipment selected for manufacturing.
Figure 1. Container Closure Integrity Pyramid illustrating CCI Assurance structural elements across facility, equipment, process, and measurement layers.
Integrity verification refers to the analytical testing methods used to demonstrate that a container closure system maintains its barrier properties. These tests provide direct evidence that the package can prevent contamination or leakage under defined conditions.
Integrity assurance, by contrast, focuses on the broader system that makes those outcomes reliable during manufacturing. It includes the design of the container closure system, the performance of the sealing equipment, the stability of the process, and the monitoring of parameters that indicate whether the process remains within its validated operating range.
In practice, CCI testing confirms that integrity is achieved on a selected and representative number of samples, while CCI assurance activities build confidence and reliability proactively, reducing or eliminating the risk of failures to occur in the first place.
Validating capping and seal quality with SmartSkin’s seal assurance system.
Seal Assurance System can be run in parallel to continuously quantify and record the immediate top load pressure applied and the sealing forces over time.
What integrity assurance looks like on the production floor
On a production line, container closure integrity is influenced by the mechanical forces containers experience as they move through filling, handling, and sealing equipment. Even small variations in shock, pressure, or container movement can affect how consistently stoppers are seated and seals are formed.
Tools such as the Quantifeel™ platform allow engineers to visualize these forces across the packaging line. By mapping where abnormal stresses occur, teams can quickly identify locations where container handling conditions may introduce variability into the sealing process.
Figure 2: Quantifeel™ Line Report: Real-time visualization of force exposure across the production path, highlighting critical zones where containers experience shock, pressure, or instability that may lead to defects or breakage.
While force mapping across the packaging line helps identify areas where containers experience abnormal mechanical stresses, understanding how the sealing process itself behaves requires more targeted measurement. This is where dedicated sealing diagnostics can provide deeper insight into the forces applied during capping and crimping of vials.
Figure 3: SmartSkin’s Seal Assurance displays seal force measurements for each capper head, helping teams quickly identify heads responsible for weak or inconsistent seals.
In fill-finish operations, container closure integrity depends on a complex interaction between materials, equipment, and process conditions.
The first layer of assurance begins with the design of the container closure system itself. The geometry of the glass vial, the properties of the elastomer stopper, and the characteristics of the aluminum seal all influence how the system behaves during crimping and the tightness of the seal remaining to protect the product over time.
The sealing process introduces another layer of complexity. During capping or crimping, the stopper must be compressed with sufficient force to create a reliable seal while maintaining consistent geometry around the vial finish. Variations in equipment setup, mechanical wear, or differences between crimping heads can introduce variability into this process.
To better understand how consistently the sealing process is operating, manufacturers often monitor sealing process indicators that provide insight into process stability.
Why sealing variability deserves attention
Sealing operations in pharmaceutical packaging lines occur at high speed and involve multiple mechanical interactions. Small variations in equipment performance can therefore influence how consistently the stopper is compressed and how the aluminum seal is formed.
Variability can originate from several sources, including differences between individual crimping heads, equipment adjustments during changeovers, mechanical wear over time, or variation in container and stopper components.
Even when finished containers pass downstream inspections, underlying mechanical variation within the sealing process may still reduce the robustness of the operation. For this reason, many manufacturers seek better ways to understand how forces behave within the sealing system itself.
Bringing process insight into sealing operations
To address this challenge, some manufacturers are turning to diagnostic technologies that provide deeper insight into the mechanical behavior of packaging lines.
SmartSkin Technologies’ Seal Assurance solution is designed to support this type of analysis. The system uses specialized Digital Container Twins that travel through capping and crimping equipment while capturing data on the forces experienced during the sealing process. These measurements can include parameters such as shock, rotation, tilt, and top load.
Joint Assessment of Capping Process Performance Using SmartSkin’s Seal Assurance System.
Assessing the capping performance of SmartSkin's Seal Assurance vial digital container twin as well as changes to seal tightness over time.
Because these Digital Container Twins can be routed through different stations and crimping heads, they allow engineers to compare performance across the entire system. This can help reveal mechanical variations that may otherwise remain difficult to detect, such as head-to-head differences in crimping force or inconsistencies introduced during line adjustments.
By identifying these sources of variation, teams can improve the consistency of the sealing process and strengthen the conditions that support reliable container closure integrity.
Importantly, these measurements are not intended to replace integrity testing. Instead, they provide additional insight into the mechanical behavior of the sealing process that ultimately contributes to consistent sealing outcomes.
Building a robust integrity strategy
Container closure integrity ultimately depends on the interaction of materials, equipment performance, and process control. Regulatory guidance increasingly encourages manufacturers to adopt lifecycle-based approaches that combine process understanding with appropriate verification methods.
Within this framework, seal quality indicators such as seal tightness can provide valuable insight into the consistency of the sealing process, while mechanical diagnostics can help identify and correct sources of variability in packaging operations.
By strengthening process capability and preventing interactions that can damage the inherent integrity of a container, or by improving and controlling the sealing mechanics, manufacturers can build a more robust Container Closure Integrity Assurance that supports reliable sterility protection throughout the lifecycle of sterile pharmaceutical products.
SmartSkin Seal Assurance
Change the way you look at container closure integrity. Verify seal tightness for every container on your sterile fill-finish line.
Dr. Simianu is considered to be an authority and sought-after speaker for pharmaceutical commercialization, quality, and innovation. She regularly speaks on data and knowledge-based R&D: product and process QbD development, validation, transfer, and life cycle management for a large range of therapeutic modalities. She sponsors and engages industry peers and partners to advance global parenteral manufacturing, parenteral products closure systems design. She engages in adoption and advancement of new technologies, adding laboratory and pilot capability as platforms for investment into rapid experimentation and change from status quo.
